Neuropathic symptoms and their risk factors in medical oncology outpatients with colorectal vs. breast, lung, or prostate cancer: Results from a prospective multicenter study

Journal of Pain and Symptom Management

Volumn 49, Issue 6, 2015, Pages 1016-1024

  Lewis, Mark A ^a   Zhao, Fengmin ^b   Jones, Desiree ^a   Loprinzi, Charles L ^c   Brell, Joanna ^d   Weiss, Matthias ^e   Fisch, Michael J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e MARSHFIELD CLINIC   (United States)

Author keywords

Colorectal cancer; neuropathic pain; neuropathy; numbness tingling; oxaliplatin

Indexed keywords

ADULT; ANOREXIA; ARTICLE; BREAST CANCER; CACHEXIA; CANCER FATIGUE; CANCER PAIN; CANCER PATIENT; COGNITIVE DEFECT; COLORECTAL CANCER; CONSTIPATION; DEPRESSION; DISEASE SEVERITY ASSESSMENT; DISTRESS SYNDROME; DROWSINESS; FEMALE; FINANCIAL DEFICIT; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH PAIN; NAUSEA; NEUROPATHIC PAIN; OUTPATIENT; PAIN ASSESSMENT; PARESTHESIA; PREVALENCE; PROSTATE CANCER; PRURITUS; RASH; RISK FACTOR; SKIN TINGLING; SLEEP DISORDER; VOMITING; WALKING DIFFICULTY; XEROSTOMIA; BREAST NEOPLASMS; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; FOLLOW UP; LUNG NEOPLASMS; MIDDLE AGED; MULTICENTER STUDY; NEURALGIA; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEURALGIA; OUTPATIENTS; PREVALENCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84931957205     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2014.11.300     Document Type: Article

References (24)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. T. André, C. Boni, and L. Mounedji-Boudiaf Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343 2351
3. T. André, C. Boni, and M. Navarro Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 2009 3109 3116
4. B.K. Bennett, S.B. Park, and C.S. Lin Impact of oxaliplatin-induced neuropathy: a patient perspective Support Care Cancer 20 2012 2959 2967
5. A.A. Argyriou, G. Cavaletti, and C. Briani Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer Cancer 119 2013 438 444
6. F. Range, H. Moslinger, and Z. Viranyi Domestication has not affected the understanding of means-end connections in dogs Anim Cogn 15 2012 597 607
7. B. Vincenzi, A.M. Frezza, and G. Schiavon Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV Support Care Cancer 21 2013 1313 1319
8. D. Kudlowitz, and F. Muggia Defining risks of taxane neuropathy: insights from randomized clinical trials Clin Cancer Res 19 2013 4570 4577
9. C.S. Cleeland, T.R. Mendoza, and X.S. Wang Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory Cancer 89 2000 1634 1646
10. R.L. Fainsinger, C.L. Nekolaichuk, and P.G. Lawlor A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients J Pain Symptom Manage 29 2005 224 237
11. R.C. Serlin, T.R. Mendoza, and Y. Nakamura When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function Pain 61 1995 277 284
12. StataCorp Stata statistical software: Release 11 2009 StataCorp LP College Station, TX
13. X.S. Wang, D.R. Fogelman, and C. Eng Prospective study of paresthetic neurotoxicity from oxaliplatin-based regimens in the treatment of colorectal cancer J Clin Oncol 28 Suppl 2010 abstr 3585
14. D. Romanus, M. Weiser, and A. TerVeer How often is adjuvant FOLFOX discontinued for toxicity among colon cancer patients in the routine care setting? J Clin Oncol 27 Suppl 2009 abstr 9530
15. C.L. Loprinzi, B.N. Reeves, and S.R. Dakhil Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1 J Clin Oncol 29 2011 1472 1478
16. S.L. Wolf, D.L. Barton, and R. Qin The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA Support Care Cancer 20 2012 625 632
17. S.Y. Zafar, J.E. Marcello, and J.L. Wheeler Longitudinal patterns of chemotherapy use in metastatic colorectal cancer J Oncol Pract 5 2009 228 233
18. C. Eng, and S. Kopetz Commentary: practice patterns and potential impact on quality measures for a practicing physician J Oncol Pract 5 2009 233 235
19. B.P. Schneider, L. Li, and K. Miller Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103 J Clin Oncol 29 Suppl 2011 abstr 1000
20. R.M. Speck, M.D. Sammel, and J.T. Farrar Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer J Oncol Pract 9 2013 e234 e240
21. C.S. Cleeland, F. Zhao, and V.T. Chang The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study Cancer 119 2013 4333 4440
22. C.L. Loprinzi, R. Qin, and S.R. Dakhil Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance) J Clin Oncol 32 2014 997 1005
23. D.L. Hershman, J.M. Unger, and K.D. Crew Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy J Clin Oncol 31 2013 2627 2633
24. D. Jones, F. Zhao, and J. Brell Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer J Cancer Surviv 9 2015 1 10